RP-HPLC method development for simultaneous estimation of empagliflozin, pioglitazone, and metformin in bulk and tablet dosage forms
Abstract
Empagliflozin, pioglitazone, and metformin are antidiabetic drugs used alone or together to treat diabetes.An economical, simple, precise, selective, and stability-indicating RP-HPLC method has been established and validated to evaluate these drugs in bulk and tablet dosage forms.ICH guidelines were followed, where the separation of the drugs using a mobile phase prepared by mixing orthophosphoric acid buffer and acetonitrile (30 : 70 v/v) adjusted to pH 2.7 was followed.An ACE C18 -(250 mm x 4.6 mm), 5 µm column at a flow rate of 0.5 mL/min at 25°C, and detection monitored at 230 nm were used.The R2 was not < 0.9998 in the range of 20-250 ppm.For stability study, drugs were studied using variant stress conditions such as base, acid, neutral, oxidation, and thermal degradation.Results were validated for the limit of detection, the limit of quantification, precision, accuracy, and linearity.The method also proved robust concerning variations in pH of the mobile phase, detector-wavelength, temperature, and mobile phase composition.The retention time of empagliflozin, metformin, and pioglitazone was 3.2 min, 2 min, and 2.6 min, respectively, with a runtime of 7 min.Detector linearity was obtained at 10-100 ppm, with the correlation coefficient for empagliflozin, pioglitazone, and metformin being 0.9994, 0.9993, and 0.9998, respectively.The low relative standard deviation, i.e., <2%, validated results, and high recovery% affirm the suitability of this method for being employed…
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.